Sulpiride
| Sulpiride | |
|---|---|
| Salts [] | |
|---|---|
| Sulpiride hydrochloride | |
| Sulpiride hydriodide | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 341.40 g/mol [1] |
| Melting point | 178 dec °C [1] |
| Solubility | 5.37e-01 g/L [1] |
| Predicted LogP | 0.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H23N3O4S |
| IUPAC name | N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide |
| SMILES | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC |
| InChI | InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) |
| InChIKey | BGRJTUBHPOOWDU-UHFFFAOYSA-N |
| CAS number | 15676-16-1 |
| UNII | 7MNE9M8287 |
| PubChem CID | 5355 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 6–8 hours[3] |
| Metabolism | Not metabolized; 95% is exerted as the unchanged drug[4][5][6][7][8] |
| Excretion | Urine (70–90%),, Feces. |
| Routes of administration | By mouth, intramuscular |
Sulpiride (also known as Sulpyrid, Sulpirid, Aiglonyl, Dogmatyl, Dolmatil, Guastil, Abilit, Coolspan, Mirbanil or Misulvan and brand names including Dogmatil) is a substance of the benzylamine class.
Chemistry
Salts []
Sulpiride is typically found in the form of its hydrochloride and hydriodide salts.
Stereochemistry []
Sulpiride is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Sulpiride matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- antipsychotics (N05A)
- benzamides (N05AL)
- (N05AL01)
- sulpiride (N05AL01)
MeSH Classification
- antipsychotic agents (M0021770)
- dopamine antagonists (M0027734)
- antidepressive agents, second-generation (M0028000)
Mechanism of action []
Sulpiride is a selective dopamine D2 and D3 receptor antagonist. _In silico_ studies show that sulpiride may interact with the Asp-119 and Phe-417 amino acid residues of these receptors. It is estimated that D2 receptors should be 65-80% occupied for optimal treatment and minimal adverse effects. [1]
Interactions []
Legal status []
- Brazil: Sulpiride is a C1.[9]
- United Kingdom: Sulpiride is Prescription only.
- Other: Sulpiride is a Rx-only.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5355, Sulpiride. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5355
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sulpiride. UNII: 7MNE9M8287. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7MNE9M8287
Brès J, Bressolle F. Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations. J Pharm Sci. December 1991; 80(12):1119–24. PMID 1815069.
Niwa T, Inoue S, Shiraga T, Takagi A. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Biological & Pharmaceutical Bulletin. January 2005; 28(1):188–191. PMID 15635191. https://doi.org/10.1248/bpb.28.188
Telles-Correia D, Barbosa A, Cortez-Pinto H, Campos C, Rocha NB, Machado S. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity. World Journal of Gastrointestinal Pharmacology and Therapeutics. February 2017; 8(1):26–38. PMID 28217372. https://doi.org/10.4292/wjgpt.v8.i1.26
Lv Q, Yi Z. Antipsychotic Drugs and Liver Injury. Shanghai Archives of Psychiatry. February 2018; 30(1):47–51. PMID 29719358. https://doi.org/10.11919/j.issn.1002-0829.217090
Kobari T, Namekawa H, Kato Y, Yamada S. Biotransformation of sultopride in man and several animal species. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. June 1985; 15(6):469–476. PMID 4036171. https://doi.org/10.3109/00498258509045020
Imondi AR, Alam AS, Brennan JJ, Hagerman LM. Metabolism of sulpiride in man and rhesus monkeys. Archives Internationales de Pharmacodynamie et de Therapie. March 1978; 232(1):79–91. PMID 96745. https://doi.org/
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 19:00:18 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 19:00:14 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 19:00:14 |
| gsrs | ok | 2026-11-20 19:00:16 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014535) | 2026-11-20 19:00:14 |
| kegg | ok | 2026-11-20 19:00:15 |
| pubchem | ok | 2026-11-20 19:00:12 |
| missing (no r/tripreports posts mention it) | 2026-11-20 19:00:14 | |
| sider | missing (not in SIDER) | 2026-11-20 19:00:14 |
| structure | ok | 2026-11-20 19:00:14 |
| wikipedia | ok | 2026-11-20 19:00:14 |